Part 1: Effect of vitamin C on the biological activity of two euryfurylbenzoquinones on TLT, a murine hepatoma cell line

European Journal of Medicinal Chemistry

Volumn 43, Issue 9, 2008, Pages 1813-1817

  Benites, Julio ^a   Rojo, Leonel ^a   Valderrama, Jaime A ^b   Taper, Henryk ^c   Calderon, Pedro Buc ^c  

^a UNIVERSIDAD ARTURO PRAT   (Chile)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^c UNIVERSITÉ CATHOLIQUE DE LOUVAIN   (Belgium)

Author keywords

Cell death; Euryfurylbenzoquinones; Reactive oxygen species; Redox cycling; Vitamin C

Indexed keywords

2 EURYFURYL 3 NITRO 1,4 BENZOQUINONE; ADENOSINE TRIPHOSPHATE; ASCORBIC ACID; BENZOQUINONE DERIVATIVE; CASPASE 3; EURYFURAN DERIVATIVE; EURYFURYLBENZOQUINONE DERIVATIVE; GLUTATHIONE; SESQUITERPENE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; DOSE RESPONSE; DRUG CYTOTOXICITY; HEPATOMA CELL; MOUSE; NONHUMAN; OXIDATION KINETICS; OXIDATION REDUCTION REACTION;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTINEOPLASTIC AGENTS; ASCORBIC ACID; BENZOQUINONES; CARCINOMA, HEPATOCELLULAR; CASPASE 3; CELL DEATH; CELL LINE, TUMOR; CELL SURVIVAL; CYTOPLASM; ENZYME ACTIVATION; GLUTATHIONE; INTRACELLULAR SPACE; L-LACTATE DEHYDROGENASE; MICE;

EID: 51149110324     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2007.11.015     Document Type: Article

References (36)

1. Hanahan D., and Weinberg R.A. Cell 100 (2000) 57-70
2. Noto V., Taper H.S., Jiang Y.H., Janssens J., Bonte J., and De Locker W. Cancer 63 (1989) 901-906
3. De Locker W., Janssens J., Bonte J., and Taper H.S. Anticancer Res. 13 (1993) 103-106
4. Sakagami H., Satoh K., Hakeda Y., and Kumegawa M. Cell Mol. Biol. 46 (2000) 129-143
5. Jamison J.M., Gilloteaux J., Taper H.S., and Summers J.L. J. Nutr. 131 (2001) 158-160
6. Calderon P.B., Cadrobbi J., Marques C., Hong-Ngoc N., Jamison J.M., Gilloteaux J., Summers J.L., and Taper H.S. Curr. Med. Chem. 9 (2002) 2271-2285
7. von Gruenigen V.E., Jamison J.M., Gilloteaux J., Lorimer H.E., Summers M., Pollard R.R., Gwin C.A., and Summers J.L. Anticancer Res. 23 (2003) 3279-3287
8. Jamison J.M., Gilloteaux J., Nassiri M.R., Venugopal N., Neal D.R., and Summers J.L. Biochem. Pharmacol. 67 (2004) 337-351
9. Gilloteaux J., Jamison J.M., Neal D.R., and Summers J.L. Ultrastruct. Pathol. 29 (2005) 221-235
10. Kassouf W., Highshaw R., Nelkin G.M., Dinney C.P., and Kamat A.M. J. Urol. 176 (2006) 1642-1647
11. Sun Y., Oberley L.W., Elwell J.H., and Sierra-Rivera E. Int. J. Cancer 44 (1989) 1028-1033
12. Verrax J., Cadrobbi J., Marques C., Taper H.S., Habraken Y., Piette J., and Calderon P.B. Apoptosis 9 (2004) 223-233
13. Agus D.B., Vera J.C., and Golde D.W. Cancer Res. 59 (1999) 4555-4558
14. Gatenby R.A., and Gawlinski E.T. Cancer Res. 63 (2003) 3847-3854
15. Kappus H. Biochem. Pharmacol. 35 (1986) 1-6
16. Roginsky V.A., Barsukova T.K., and Stagman H.B. Chem. Biol. Interact. 121 (1999) 177-197
17. Verrax J., Stockis J., Tison A., Taper H.S., and Calderon P.B. Biochem. Pharmacol. 72 (2006) 671-680
18. Verrax J., Delvaux M., Beghein N., Taper H.S., Gallez B., and Calderon P.B. Free Radic. Res. 39 (2005) 649-657
19. Verrax J., Vanbever S., Stockis J., Taper H.S., and Calderon P.B. Int. J. Cancer 120 (2007) 1192-1197
20. Valderrama J.A., Benites J., Cortés M., Pessoa-Mahana H., Prina E., and Fournet A. Tetrahedron 58 (2002) 881-886
21. Valderrama J.A., Benites J., Cortés M., Pessoa-Mahana H., Prina E., and Fournet A. Bioorg. Med. Chem. 11 (2003) 4713-4718
22. Barrero A.F., Alvarez-Manzaneda E., Herrador M., Chahboun R., and Galera P. Bioorg. Med. Chem. Lett. 9 (1999) 2325-2328
23. Loya S., Tal R., Kashman Y., and Hizi A. Antimicrob. Agents Chemother. 10 (1990) 2009-2012
24. Bourguet-Kondracki M.L., Longeon A., Morel E., and Guyot M. Int. J. Immunopharmacol. 13 (1991) 393-399
25. Duerksen J.D., and Paul I.J. Nucleic Acids Res. 3 (1976) 2277-2291
26. Taper H.S., de Gerlache J., Lans J.M., and Roberfroid M. Int. J. Cancer 40 (1987) 575-579
27. Jordan B.F., Gregoire V., Demeure R.J., Sonveaux P., Feron O., O'Hara J., Vanhulle V., Delzenne N., and Gallez B. Cancer Res. 62 (2002) 3555-3561
28. Traven V.F. Frontier Orbitals and Properties of Organic Molecules (1992), Ellis Horwood Limited, New York
29. Tudor G., Gutiérrez P., Aguilera-Gutiérrez A., and Sausville E.A. Biochem. Pharmacol. 65 (2003) 1061-1075
30. Hampton M.B., and Orrenius S. FEBS Lett. 414 (1997) 552-556
31. Hardy J.A., Lam J., Nguyen J.T., O'Brien T., and Wells J.A. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 12461-12466
32. Wang X., Thomas B., Sachdeva R., Arterburn L., Frye L., Hatcher P.G., Cornwell D.G., and Ma J. Proc. Natl. Acad. Sci. U.S.A. 13 (2006) 3604-3609
33. Ishihara Y., Shiba D., and Shimamoto N. Free Radic. Res. 39 (2005) 163-173
34. Wroblesky F., and Ladue J. Proc. Soc. Exp. Biol. Med. 90 (1955) 210-213
35. Lowry O., Rosebrough N., Farr L., and Randall R. J. Biol. Chem. 183 (1951) 265-275
36. Cohn V.H., and Lyle J.A. Anal. Biochem. 14 (1966) 434-440